Vedolizumab as a Potential Culprit in the Development of Ovarian Teratoma?
We present the case of a patient who developed an ovarian teratoma after initiation of vedolizumab therapy.Case Rep Gastroenterol 2017;11:786 –790
Source: Case Reports in Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cancer & Oncology | Crohn's Disease | Gastroenterology | Inflammatory Bowel Disease | Ovaries | Study | Teratoma | Ulcerative Colitis